Protagonist Therapeutics, Inc. (PTGX)
NASDAQ·Healthcare·Biotechnology
$138.93
-4.23%
Mkt Cap $9.20B
Analyst Ratings
Buy
16
Hold
0
Sell
0
Price Target (18 analysts)
$123.25
Range $110.00 – $145.00
Implied Upside
-11.3%
Consensus $123.25 vs current $138.93